Insys Plans $29M CBD And Naloxone Sale In Ch. 11
Embattled and bankrupt drugmaker Insys Therapeutics Inc. has entered into agreements to sell the company's naloxone spray and cannabis-based products to a pair of companies for a total of $29 million,...To view the full article, register now.
Already a subscriber? Click here to view full article